임신 중 gemfibrozil을 피해야 할까요? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

gemfibrozil은 임신 중 안전한가요?

Animal reproductive and developmental toxicity (rats/rabbits) reported (dose-related decreases in conception, increased stillbirths, fetal skeletal variations and rare anophthalmia); regulatory/product literature flags suspected reproductive toxicity (H361) though no clear harmonised CLP entry was found. Mechanism is not well‑characterized for reproductive effects; likely related to pharmacologic/lipid‑metabolism effects seen with systemic exposure. Topical cosmetic exposure would give low but measurable systemic absorption in typical circumstances, so exposure is not negligible for pregnancy concerns. Sources: Drugs.com summary (drug pregnancy warnings), product monograph and animal study summaries, SDS/classification listings.

gemfibrozil은 모유 수유 중 안전한가요?

Authoritative lactation sources (LactMed / drug monographs) advise avoidance during breastfeeding because of concern for disruption of infant lipid metabolism and because gemfibrozil is systemically absorbed and may transfer to milk. Reproductive/developmental animal data support suspected hazard. Topical cosmetic use would generally give low exposure, but milk transfer risk under systemic use is established. Sources: LactMed, product monograph, Drugs.com.

gemfibrozil은 아기 피부에 안전한가요?

Because animal developmental toxicity has been observed, hazard for infants is flagged as suspected (H361 in several supplier/SDS listings and regulatory summaries). For infant skin (0–3 yr) exposure, immature skin increases absorption; therefore exposure score is increased by +1 relative to adult topical exposure. There are no infant‑specific dermal studies for gemfibrozil in cosmetics, and no SCCS/CIR cosmetic safety opinion was located; concern is driven by systemic reproductive/developmental toxicity observed in animal studies and regulatory/product literature. Sources: SDSs and product monograph reporting reproductive effects, LactMed, animal study summaries.

VeriMom은 gemfibrozil을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 gemfibrozil을 27/100 (높은 위험)로 평가합니다.

임신 중 gemfibrozil 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.